跨癌症亚型向HER2的进展 - 一种全瘤方法
Taiwo Adesoye1, Ecaterina E Dumbrava2, Kanwal P S Raghav2
1The University of Texas MD Anderson Cancer Center, Houston, United States.
概括
针对HER2的疗法正在彻底改变癌症治疗的方法,不仅仅是乳腺癌和胃癌. 本综述探讨了对表达HER2的固体瘤的当前和新兴策略,旨在改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 人类表皮生长因子受体2 (HER2) 是乳腺癌和胃癌的关键治疗标.
- 针对HER2的治疗方法显著改善了HER2阳性转移性癌症患者的治疗结果.
- 在其他固体瘤中也发现了HER2表达,这为新的治疗机会提供了新的治疗机会.
研究的目的:
- 审查目前在各种固体瘤中针对HER2的治疗策略.
- 探索新兴疗法,耐药性机制和生物标志物驱动的选择.
- 提供对HER2驱动恶性瘤精密瘤学的未来方向的见解.
主要方法:
- 目前和新兴的HER2向疗法的文献综述.
- 对临床疗效,不良事件和耐药机制的分析.
- 检查患者选择的诊断工具和生物标志物策略.
主要成果:
- 针对HER2的疗法,包括ADC和双特异性抗体,在各种固体瘤中显示出有前途.
- 克服耐药性和解决异质性的策略对于治疗优化至关重要.
- 生物标志物驱动的选择和精确瘤学是扩大治疗效益的关键.
结论:
- 针对HER2的疗法在更广泛的固体瘤中具有显著的潜力.
- 解决耐药性和优化患者选择对于最大限度地提高治疗疗效至关重要.
- 未来的研究应该专注于精密瘤学方法,以扩大治疗机会.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.8K
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
13.0K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K